Richard Larson to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Richard Larson has written about Antineoplastic Agents, Immunological.
Connection Strength
0.374
-
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia. Blood Adv. 2025 May 13; 9(9):2144-2152.
Score: 0.189
-
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study. Cancer. 2025 Feb 15; 131(4):e35750.
Score: 0.186